Press Release

AI Powered Retina Image Analysis Market to Grow at CAGR of 7.03% through 2030

Rise of telemedicine and remote diagnosis and increased demand for AI-powered retina image analysis solutions is expected to drive the Global AI Powered Retina Image Analysis Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “AI Powered Retina Image Analysis Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2020-2030F”, the Global AI Powered Retina Image Analysis Market stood at USD 1.02 Billion in 2024 and is expected to reach USD 1.54 Billion by 2030 with a CAGR of 7.03% during the forecast period.          

The Global AI Powered Retina Image Analysis Market is witnessing a period of rapid evolution, driven by significant advancements in artificial intelligence (AI) and machine learning (ML) technologies, which are revolutionizing the way retinal diseases, such as diabetic retinopathy and glaucoma, are diagnosed and monitored. As healthcare continues to embrace digital solutions, AI-based retina image analysis tools are gaining increasing traction for their ability to automate the diagnostic process, improve accuracy, and reduce the workload of healthcare professionals. This technology is reshaping traditional diagnostic methods by enabling faster, more consistent, and efficient analysis of retinal images, which is critical for the early detection of vision-threatening conditions.

The growth of the market is largely fueled by the rising prevalence of chronic diseases like diabetes, which is one of the most significant risk factors for retinal diseases. Diabetic retinopathy, for example, is one of the leading causes of blindness globally, particularly in developed regions. As the global population of diabetics continues to rise, the demand for early and reliable detection methods becomes more pressing. AI-powered retina image analysis is well-suited to meet this demand by automating the screening process and enabling rapid identification of early signs of diabetic retinopathy, such as microaneurysms, hemorrhages, and exudates. AI systems can be trained on vast datasets of retinal images, learning to recognize these subtle changes with accuracy that rivals, and sometimes exceeds, that of human clinicians. This makes AI a crucial tool in reducing the burden of diabetic retinopathy and other retinal diseases on healthcare systems, especially in countries with a shortage of ophthalmologists.

The integration of AI in retina image analysis is not limited to the detection of diabetic retinopathy alone. It also extends to conditions like glaucoma, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). As AI systems continue to evolve, their capabilities to detect a wide range of retinal diseases are improving. AI algorithms are increasingly capable of identifying optic disc abnormalities, assessing retinal nerve fiber layers, and evaluating the morphology of the retina, all of which are essential for diagnosing conditions like glaucoma and AMD. The potential for AI to provide accurate, real-time insights into the health of the retina has created a surge in demand for AI-powered solutions across the healthcare sector.

The market is being driven by the growing emphasis on telemedicine and remote patient monitoring. With the increasing adoption of telehealth services, particularly in rural or underserved areas, AI-powered retina image analysis tools are enabling remote screening of retinal diseases. This capability is particularly valuable in regions with limited access to ophthalmologists or specialized eye care professionals. AI can assist general practitioners or telemedicine platforms in quickly analyzing retinal images, providing preliminary diagnoses, and recommending appropriate courses of action. This democratization of healthcare access is expected to be a key driver of market growth, especially in emerging markets where there is a pressing need for cost-effective and scalable solutions.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global AI Powered Retina Image Analysis Market

 

The Global AI Powered Retina Image Analysis Market is segmented into type, application, regional distribution, and company.

Based on type, the Glaucoma Detection holds the second dominant position after Diabetic Retinopathy Detection in the Global AI Powered Retina Image Analysis Market due to several factors, including the growing prevalence of the condition, advancements in AI technology, and the critical need for early diagnosis to prevent irreversible vision loss. While diabetic retinopathy (DR) remains the leading cause for AI integration in retinal diagnostics, glaucoma detection is rapidly gaining importance as the second most prioritized condition, especially with the rising global awareness of the disease and its impact on public health.

Glaucoma is a group of eye diseases that cause damage to the optic nerve, often due to increased intraocular pressure (IOP). It is one of the leading causes of blindness worldwide, and its progression is often slow and painless, making early detection essential for preventing significant vision loss. Early intervention through regular monitoring is critical because, once vision loss occurs due to glaucoma, it is typically irreversible. This has led to an increasing demand for more efficient and accurate diagnostic tools, which is where AI-powered retina image analysis has become a game-changer.

AI technologies have proven highly effective in assisting healthcare providers in diagnosing glaucoma by analyzing retinal images, specifically examining the optic nerve and optic disc for signs of damage or abnormality. AI systems can precisely assess the size and shape of the optic nerve head, the nerve fiber layer, and other key markers indicative of glaucoma. AI models trained on large datasets of retinal scans are able to detect subtle changes that could signify the onset of glaucoma much earlier than traditional methods. This makes AI-powered systems an essential tool in managing glaucoma patients and in the effort to detect the disease at an earlier, more treatable stage.

One of the reasons for glaucoma detection being second in dominance is its growing recognition as a major global health threat. The World Health Organization (WHO) has identified glaucoma as one of the leading causes of blindness, with the disease's prevalence expected to rise as the global population ages. The aging population is a particularly important factor because the risk of developing glaucoma increases with age. As such, as populations in regions like North America, Europe, and Asia Pacific age, the demand for early and effective detection of glaucoma continues to grow. In response, the healthcare industry is looking for solutions to handle the increasing burden of glaucoma diagnoses, making AI-powered tools an appealing choice for healthcare providers looking to improve the speed and accuracy of screenings.

Based on region, Europe is the second-dominating region in the Global AI Powered Retina Image Analysis Market, following North America, and is expected to maintain its strong position due to a combination of factors including advanced healthcare infrastructure, high adoption rates of AI technologies, and a growing focus on managing chronic retinal diseases such as diabetic retinopathy and glaucoma. Europe’s healthcare system is well-established and highly developed, with a long history of adopting advanced technologies in medical diagnostics. This makes it an ideal environment for the integration of AI-powered retina image analysis tools, particularly in countries like the United Kingdom, Germany, France, and the Netherlands, where healthcare providers are increasingly leveraging AI to improve diagnostic accuracy and patient care.

A significant driver for Europe's strong performance in the AI-powered retina image analysis market is the increasing prevalence of chronic diseases like diabetes and age-related macular degeneration (AMD). In Europe, the rise in the diabetic population and an aging demographic have amplified the need for efficient and reliable methods of detecting retinal conditions early. Diabetic retinopathy is one of the leading causes of vision impairment in Europe, and as the number of individuals with diabetes continues to grow, AI-powered solutions for early detection and monitoring are becoming more crucial. Similarly, Europe’s aging population is contributing to the rise in retinal conditions like glaucoma and macular degeneration, further fueling demand for advanced diagnostic technologies.

 

Major companies operating in Global AI Powered Retina Image Analysis Market are:

  • Altris, Inc
  • EarlySight SA
  • Eyenuk, Inc.
  • LumiThera, Inc.
  • Mediwhale Inc.
  • Optina Diagnostics
  • Optos plc
  • PulseMedica Corp.
  • Ikerian AG
  • RetInSight GmbH

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The future of the Global AI Powered Retina Image Analysis Market looks promising, with rapid advancements in artificial intelligence and machine learning technologies driving innovation in retinal disease diagnostics. As the global prevalence of chronic conditions like diabetes and glaucoma continues to rise, demand for accurate, early detection methods will grow, boosting market expansion. Increasing healthcare digitization, the rise of telemedicine, and regulatory support will further accelerate adoption across both developed and emerging markets. AI-driven solutions will enhance diagnostic accuracy, streamline workflows, and improve patient outcomes. With further improvements in AI algorithms and greater integration into healthcare systems, the market is poised for substantial growth, making AI-powered retina image analysis a cornerstone in ophthalmic care in the coming years.,” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

AI Powered Retina Image Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Diabetic Retinopathy Detection, Glaucoma Detection, and Others), By Application (Ophthalmic Clinic, Hospital, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global AI Powered Retina Image Analysis Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global AI Powered Retina Image Analysis Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant Reports

AI Powered Retina Image Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Diabetic Retinopathy Detection, Glaucoma Detection, and Others), By Application (Ophthalmic Clinic, Hospital, Others), By Region and Competition, 2020-2030F

Healthcare | Feb, 2025

Technological advancements in AI and machine learning and increasing global prevalence of retinal diseases are factors driving the Global AI Powered Retina Image Analysis market in the forecast period 2026-2030.

Relevant News